Algorithmic Revolution in Life Sciences and Healthcare Research
AI and machine learning are rapidly reshaping how we investigate, model, and manipulate living systems, from uncovering new biological principles to rethinking what it means to truly understand a cell or organism. Reprogramming Life explores how computational models are enabling new forms of discovery while raising critical questions about interpretation, safety, and accountability. It considers the emerging possibility of “reprogramming” biological and human systems and the ethical, legal, and governance challenges that accompany these advances. By connecting scientific innovation with questions of trust, patient rights, and public health, this series examines how AI can responsibly complement human intuition in research, medicine, and society.
Leads: Robert Klitzman, Bioethics; Charles Binkley, Bioethics; Florence Hudson, Northeast Big Data Innovation Hub
Core Collaborators: Siddhartha Dalal Dalal, Applied Analytics and Statistics; Chunhua Weng, Biomedical Informatics; Matthew McDermott, Biomedical Informatics; Sarah Collins Rossetti, Biomedical Informatics and Nursing; Bethany Percha, Medicine, Genetics, and Genomic Sciences (Mount Sinai); Paul Appelbaum, Psychiatry; Whitney Zatzkin (BIO-ISAC); Noémie Elhadad, Biomedical Informatics; Charles Fracchia (BIO-ISAC); Barbra B. Rothschild, Bioethics; Shuguang Zhang, Molecular Architecture (MIT); Katherine Mendis, Bioethics; Glenn Cohen, Law, Harvard; David N. Hoffman, Bioethics; Vardit Ravitsky, Bioethics (Hastings Center); Anne S. Zimmerman, Bioethics.
Awarded: Fall 2025Events & Activities: Spring 2026
AI is increasingly shaping clinical decision-making and biomedical modeling, raising important questions about safety, accountability, and trust. One central challenge is how clinicians should respond when their judgment differs from AI-generated predictions, including subclinical findings that cannot be confirmed, unexplainable decision support during procedures, and the ethical and legal issues surrounding disclosure and documentation. A second area of concern is the growing use of biomedical “digital twins,” which introduces new questions about security, privacy, data governance, and the ethical frameworks needed to guide their use. Together, these topics highlight the need to define how AI should fit into clinical care, how patient rights should be protected, and what standards are required for responsible and equitable use of emerging health technologies.
Program Overview: Through full-day conferences held on the Morningside and CUIMC campuses, this series will bring clinicians, ethicists, technologists, and policy leaders into dialogue to shape recommendations, frameworks, and standards for the ethical and secure deployment of AI in healthcare.
Leads: Lena Mamykina, Biomedical Informatics; James L. David, Social Work; Nabila El-Bassel, Social Work; Orson Xu, Biomedical Informatics
Awarded: Fall 2025Events & Activities: Spring 2026 through Fall 2026
Generative AI is opening new possibilities for personal health and mental wellness, offering scalable, low-cost, and continuously accessible support—particularly for underserved or hard-to-reach communities. At the same time, emerging research highlights serious concerns about safety, accuracy, equity, and appropriateness, especially when AI tools are used in sensitive contexts such as mental health or substance use. Professional organizations and regulators are calling for stronger guardrails, clearer standards, and more meaningful inclusion of people with lived experience to ensure these systems do not reinforce stigma, exacerbate inequalities, or cause harm. This series aims to chart responsible paths forward for designing and deploying generative AI in personal health.
Program Overview: This workshop series will convene faculty, researchers, and community voices through four dedicated workshops on equity and inclusion, AI as companion, health information seeking, and community narratives.
Leads: Sandra Soo-Jin Lee, Medical Humanities and Ethics; Noémie Elhadad, Biostatistics; Chris Wiggins, Applied Physics and Applied Mathematics
Awarded: Fall 2025Events & Activities: Fall 2026
AI is expanding across healthcare and the life sciences, influencing everything from diagnostics to precision medicine. These developments raise profound ethical, legal, and societal concerns, including bias and inequitable outcomes, privacy and surveillance, the reshaping of clinical expertise and labor, the concentration of power, and the environmental costs of large-scale computation. Existing oversight frameworks, including Institutional Review Boards, are not designed to engage these broader challenges. With its strengths in data science, medicine, ethics, law, the social sciences, and the humanities, Columbia is uniquely positioned to guide national conversations on the responsible governance of health-related AI. This initiative will explore and help shape the foundations for ethical stewardship, accountability, and trustworthiness of AI in clinical care and biomedical research.
Program Overview: Through a series of symposia, workshops, roundtable discussions, and a hackathon, this program will convene faculty, students, national experts, and stakeholder communities to develop new approaches for multi-stakeholder oversight in health and medicine.
New events and their related programs will be added here on a rolling basis. Please bookmark the DSI Events Calendar and subscribe to the DSI Newsletter to attend upcoming Frontiers events.